Carisma Therapeutics (NASDAQ:CARM – Get Rating) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, Marketbeat reports. The brokerage presently has a $7.00 price objective on the stock. Jefferies Financial Group’s price target would indicate a potential upside of […]
HC Wainwright reissued their buy rating on shares of Carisma Therapeutics (NASDAQ:CARM – Get Rating) in a research note released on Wednesday morning, Marketbeat.com reports. They currently have a $10.00 target price on the stock. HC Wainwright also issued estimates for Carisma Therapeutics’ Q2 2023 earnings at ($0.66) EPS, Q3 2023 earnings at ($0.71) EPS, […]
Analysts’ new coverage for Wednesday, May 24th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on shares of Ambev (NYSE:ABEV). They […]
Analysts’ new coverage for Wednesday, May 24th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on shares of Ambev (NYSE:ABEV). They […]